Your browser doesn't support javascript.
loading
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
Eleftheriou, Phaedra; Amanatidou, Dionysia; Petrou, Anthi; Geronikaki, Athina.
Affiliation
  • Eleftheriou P; Department of Biomedical Sciences, School of Health, International Hellenic University, 57400 Thessaloniki, Greece.
  • Amanatidou D; Department of Biomedical Sciences, School of Health, International Hellenic University, 57400 Thessaloniki, Greece.
  • Petrou A; Department of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Geronikaki A; Department of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Molecules ; 25(11)2020 May 29.
Article in En | MEDLINE | ID: mdl-32485894
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Protease Inhibitors / Viral Nonstructural Proteins / Dipeptidyl-Peptidase IV Inhibitors / Betacoronavirus / Anticoagulants Type of study: Prognostic_studies Language: En Journal: Molecules Journal subject: BIOLOGIA Year: 2020 Type: Article Affiliation country: Greece

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Protease Inhibitors / Viral Nonstructural Proteins / Dipeptidyl-Peptidase IV Inhibitors / Betacoronavirus / Anticoagulants Type of study: Prognostic_studies Language: En Journal: Molecules Journal subject: BIOLOGIA Year: 2020 Type: Article Affiliation country: Greece